Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The report for the Warfarin Clopidogrel Drug Response Test can be obtained for a maximum of 7 days from the date of the test.

What are the prerequisites for the test Warfarin Clopidogrel Drug Response Test

  • Patient must be currently taking warfarin and clopidogrel medications
  • Patient must not have any known allergies to warfarin or clopidogrel
  • Patient must not have any history of bleeding disorders
  • Patient must not have any history of liver or kidney disease
  • Patient must not be pregnant or breastfeeding

What are the measure values for the test Warfarin Clopidogrel Drug Response Test

  • PT/INR (Prothrombin Time/International Normalized Ratio): This measures how long it takes for blood to clot and is used to monitor the effectiveness of warfarin therapy. The target range for PT/INR varies depending on the reason for anticoagulation but is typically between 2.0 and 3.0.
  • CYP2C9 Genotyping: This test identifies genetic variations that may affect how a person metabolizes warfarin. The results can help determine the appropriate dose of warfarin for an individual.
  • CYP2C19 Genotyping: This test identifies genetic variations that may affect how a person metabolizes clopidogrel. The results can help determine the appropriate dose of clopidogrel for an individual.
  • Platelet Function Assay: This test measures the ability of platelets to aggregate and is used to monitor the effectiveness of clopidogrel therapy. The results are reported as a percentage of platelet inhibition, with higher values indicating better response to the medication.

What does this test Warfarin Clopidogrel Drug Response Test identify?

Warfarin Clopidogrel Drug Response Test

The Warfarin Clopidogrel Drug Response Test is a genetic test that identifies how an individual's body processes two common blood thinning medications, Warfarin and Clopidogrel. These medications are commonly prescribed to prevent blood clots and reduce the risk of heart attacks and strokes.

The test analyzes specific genetic markers that can affect how an individual responds to these medications. For Warfarin, the test can help determine the appropriate dose to achieve the desired anticoagulant effect while minimizing the risk of bleeding. For Clopidogrel, the test can identify individuals who may not respond well to the medication due to genetic factors, allowing for alternative treatment options to be considered.

Overall, the Warfarin Clopidogrel Drug Response Test can help healthcare providers personalize medication regimens for their patients, leading to more effective and safer treatment outcomes.

Why is this test Warfarin Clopidogrel Drug Response Test taken?

Warfarin Clopidogrel Drug Response Test

Why is this test taken?

The Warfarin Clopidogrel Drug Response Test is taken to determine how an individual's body metabolizes and responds to the medications Warfarin and Clopidogrel.

Warfarin is a blood thinner that is commonly prescribed to prevent blood clots, while Clopidogrel is a medication used to reduce the risk of heart attacks and strokes. Both of these medications require careful monitoring to ensure they are working effectively and are not causing any harmful side effects.

This test helps healthcare providers adjust the dosage of these medications based on an individual's genetic makeup, allowing for personalized and more effective treatment. It can also help identify potential drug interactions and reduce the risk of adverse reactions.

Overall, the Warfarin Clopidogrel Drug Response Test is taken to optimize the effectiveness and safety of these medications for each patient.

No FAQs available.

Customer Google Rating